But given that this population of children carries an elevated risk for additional autoimmune (autoimmune thyroiditis, celiac disease, multiple sclerosis) and inflammatory conditions (atherosclerosis, depression, sleep disorders) (Dietert and Zelikoff 2009), insulin and glucose management alone is unlikely to correct underlying immune dysfunction. Here, INS is linked to depressive symptom measurement.